Ironwood Pharmaceuticals, Inc.
NASDAQ:IRWD · NASDAQ Global Select
+$0.01 today
Vol 4.93M · Avg 2.35M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+425.69%
Period High
$5.39
Period Low
$0.67
Latest
$3.54
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
BioAge Labs, Inc.
NASDAQ:BIOA
$775.07M
NeuroPace, Inc.
NASDAQ:NPCE
$518.91M
Canopy Growth Corporation
NASDAQ:CGC
$402.02M
Silence Therapeutics plc
NASDAQ:SLN
$324.73M
Cellectis S.A.
NASDAQ:CLLS
$316.31M
Alpha Teknova, Inc.
NASDAQ:TKNO
$275.58M
Lifecore Biomedical, Inc.
NASDAQ:LFCR
$208.55M
Aurora Cannabis Inc.
NASDAQ:ACB
$165.68M
Aldeyra Therapeutics, Inc.
NASDAQ:ALDX
$117.32M
Genelux Corporation
NASDAQ:GNLX
$108.90M
What is the latest IRWD filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does IRWD have?
Intrinsic Alpha currently shows 20 recent filings for IRWD.
Explore More
Continue the stock analysis
Jump to another research area for this company.